Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2019-03-20
CHRSCoherus Biosciences, Inc.Viret Jean-FredericCFOS - Sale$14.92-3,00013,185-19%-$44,762
D
2019-03-21
FATEFate Therapeutics IncWolchko J ScottPres, CEOS - Sale+OE$17.61-20,000374,881-5%-$352,160
A
2019-01-07
NITENightstar Therapeutics PlcFellows David ACEOS - Sale$12.98-8,733626,395-1%-$113,361
D
2019-03-20
GILDGilead Sciences IncCogan John FrancisDirS - Sale+OE$65.07-2,70054,860-5%-$175,689
D
2019-03-19
RGNXRegenxbio Inc.Mills Kenneth T.Pres, CEOS - Sale+OE$58.53-15,000246,000-6%-$877,989
A
2019-03-19
APTOAptose Biosciences Inc.Platzer ErichDirP - Purchase$2.19+20,000135,000+17%+$43,805
D
2019-03-18
MNTAMomenta Pharmaceuticals IncDowney BruceDirS - Sale+OE$14.51-13,00028,234-32%-$188,630
D
2019-03-18
EDITEditas Medicine, Inc.Myer VickeshCTOS - Sale+OE$24.50-3,0000-100%-$73,500
2019-03-19
APTOAptose Biosciences Inc.Platzer ErichDirS - Sale$2.19-20,000135,000-13%-$43,805
2019-03-18
RGENRepligen CorpHunt AnthonyCEOS - Sale$59.63-14,550215,107-6%-$867,633
D
2019-03-15
RUBYRubius Therapeutics, Inc.Carpenter Christopher L.Chief Medical OfficerS - Sale+OE$15.84-48,00034,843-58%-$760,114
2019-03-18
MNTAMomenta Pharmaceuticals IncBeltramello Jo AnnChief HR, Inf. OfficerS - Sale$14.20-29,167112,166-21%-$414,171
2019-03-15
MNTAMomenta Pharmaceuticals IncFier IanChief Mfg, Program OfficerS - Sale$13.92-10,00077,566-11%-$139,200
2019-03-15
ATRAAtara Biotherapeutics, Inc.Marcus Joel SDirS - Sale$38.25-20,000899,855-2%-$765,000
D
2019-03-18
BIIBBiogen Inc.Pangia Robert WDirS - Sale+OE$328.55-6,11418,587-25%-$2,008,755
2019-03-19
HEBHemispherx Biopharma IncEquels Thomas K.Exec. Vice COB, CEO, PresP - Purchase$0.18+13,400811,707+2%+$2,352
D
2019-03-15
SGMOSangamo Therapeutics, IncYi KathyEVP, CFOS - Sale+OE$10.00-5,00025,512-16%-$50,000
D
2019-03-14
DNLIDenali Therapeutics Inc.Ho CaroleChief Medical OfficerS - Sale+OE$25.01-1,000213,9900%-$25,010
M
2019-03-14
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$39.48-7,800659,980-1%-$307,953
2019-03-14
ASRTAssertio Therapeutics, IncHiggins Arthur JDir, Pres, CEOP - Purchase$4.17+10,000190,879+6%+$41,700
2019-03-14
APTOAptose Biosciences Inc.Rice William G.Chair, Pres, CEOP - Purchase$1.90+10,000143,014+8%+$18,993
D
2019-03-13
BLUEBluebird Bio, Inc.Davidson DavidChief Medical OfficerS - Sale+OE$146.41-3,10131,616-9%-$454,005
2019-03-14
NSTGNanostring Technologies IncGray R BradleyPres, CEOS - Sale$0.28-60,00076,530-44%-$16,500
2019-03-13
APTOAptose Biosciences Inc.Chow Gregory K.SVP, CFOP - Purchase$1.75+15,000127,014+13%+$26,322
2019-03-12
VYGRVoyager Therapeutics, Inc.Neurocrine Biosciences Inc10%P - Purchase$11.96+4,179,7284,179,728New+$49,999,996
2019-03-12
BCRXBiocryst Pharmaceuticals IncAselage SteveDirP - Purchase$8.30+2,0002,000New+$16,600
M
2019-03-11
DNLIDenali Therapeutics Inc.Schuth Alexander O.COO, SecretaryS - Sale$22.58-7,500670,827-1%-$169,313
D
2019-03-11
BLUEBluebird Bio, Inc.Walsh Jeffrey T.Chief Strategy OfficerS - Sale+OE$139.80-1,50040,921-4%-$209,698
D
2019-03-08
SGENSeattle Genetics Inc /waSiegall Clay BPres, CEOS - Sale+OE$69.19-20,148732,613-3%-$1,394,094
D
2019-03-08
SGENSeattle Genetics Inc /waHimes Vaughn BChief Technical OfficerS - Sale+OE$68.72-8,000177,329-4%-$549,746
2019-03-11
VCELVericel CorpMichel Gerard JCFO, VP, Corp. DevelopmentS - Sale$20.02-10,000122,249-8%-$200,235
D
2019-03-06
AMGNAmgen IncSugar Ronald DDirS - Sale+OE$188.88-2,00012,988-13%-$377,760
2019-03-08
CDTXCidara Therapeutics, Inc.Abdollahian NeilChief Business OfficerS - Sale$2.44-2,30030,472-7%-$5,612
2019-03-07
CDTXCidara Therapeutics, Inc.Daruwala PaulCOOS - Sale$2.55-2,24049,567-4%-$5,714
D
2019-03-05
BLUEBluebird Bio, Inc.Gregory Philip DChief Scientific OfficerS - Sale+OE$147.71-1,80032,592-5%-$265,879
2019-03-05
RGNXRegenxbio Inc.Vasista VittalCFOS - Sale$60.01-3,068239,215-1%-$184,111
2019-03-05
EDITEditas Medicine, Inc.Hopfield JessicaDirP - Purchase$23.94+10,20016,900+152%+$244,188
2019-03-04
SGENSeattle Genetics Inc /waSimpson Todd ECFOS - Sale$75.00-10,000184,280-5%-$750,000
D
2019-03-04
KLDOKaleido Biosciences, Inc.Flagship Ventures Fund V General Partner LLCDir, 10%P - Purchase$15.00+933,3334,744,305+24%+$13,999,995
D
2019-03-04
BLUEBluebird Bio, Inc.Davidson DavidChief Medical OfficerS - Sale+OE$155.77-4,91031,616-13%-$764,832
D
2019-03-01
SGMOSangamo Therapeutics, IncYi KathyEVP, CFOS - Sale+OE$10.00-5,00025,512-16%-$50,000
D
2019-03-01
ATRAAtara Biotherapeutics, Inc.Newell JoeChief Tech. Operations OfficerS - Sale+OE$36.13-1,50047,146-3%-$54,202
DM
2019-03-01
DNLIDenali Therapeutics Inc.Ho CaroleChief Medical OfficerS - Sale+OE$22.17-17,500214,490-8%-$388,000
M
2019-03-01
DNLIDenali Therapeutics Inc.Watts Ryan J.Pres, CEOS - Sale$22.18-18,3332,628,476-1%-$406,601
M
2019-03-01
CRSPCrispr Therapeutics AGNovak RodgerPresS - Sale$40.40-85,220948,007-8%-$3,443,037
2019-03-05
RGENRepligen CorpHunt AnthonyCEOS - Sale$58.50-13,000229,657-5%-$760,500
2019-03-05
RGENRepligen CorpKuriyel RalfSVP, R, DS - Sale$58.53-2,24018,803-11%-$131,107
2019-03-05
RGENRepligen CorpSnodgres JonCFOS - Sale$58.52-2,64527,001-9%-$154,785
D
2019-03-01
MGTXMeiragtx Holdings PlcPerceptive Life Sciences Master Fund Ltd10%P - Purchase$13.80+1,304,3486,007,746+28%+$18,000,002
D
2019-03-01
FATEFate Therapeutics IncTahl CindyGC, SecretaryS - Sale+OE$16.15-25,00090,418-22%-$403,698
D
2019-02-28
KLDOKaleido Biosciences, Inc.Bonney Michael WExec ChairP - Purchase$13.97+71,5201,651,196+5%+$999,493
D
2019-02-28
RGENRepligen CorpSnodgres JonCFOS - Sale+OE$58.88-1,87524,946-7%-$110,400
D
2019-02-28
RGENRepligen CorpHunt AnthonyCEOS - Sale+OE$59.01-7,475242,657-3%-$441,100
D
2019-02-28
RGENRepligen CorpKuriyel RalfSVP, R, DS - Sale+OE$59.16-18516,343-1%-$10,945
2019-02-28
BLUEBluebird Bio, Inc.Wentworth Kory JamesPrincipal Accounting OfficerS - Sale$151.71-516,695-1%-$7,737
D
2019-02-28
VCELVericel CorpGilman Steven CDirS - Sale+OE$18.02-7,5000-100%-$135,129
M
2019-02-27
NSTGNanostring Technologies IncAllen Mary TeddSVP, OperationsS - Sale$25.16-11,25013,946-45%-$283,061
2019-02-27
ONCESpark Therapeutics, Inc.Children'S Hospital of Philadelphia Foundation10%S - Sale$113.00-2,000,0001,954,957-51%-$226,000,000
M
2019-02-27
ATRAAtara Biotherapeutics, Inc.Ciechanover Isaac E.CEOS - Sale$36.14-7,800667,780-1%-$281,891
D
2019-02-28
ATRAAtara Biotherapeutics, Inc.Marcus Joel SDirS - Sale+OE$36.07-62,590919,855-6%-$2,257,621
D
2019-02-25
RGNXRegenxbio Inc.Simpson CurranSVP, Product Development, CTOS - Sale+OE$54.05-5,30039,500-12%-$286,465
D
2019-02-25
BLUEBluebird Bio, Inc.Cole JasonCOO andS - Sale+OE$150.24-6,24826,444-19%-$938,698
2019-02-25
BLUEBluebird Bio, Inc.Wentworth Kory JamesPrincipal Accounting OfficerS - Sale$150.00-2086,746-3%-$31,201
D
2019-02-25
BOLDAudentes Therapeutics, Inc.Prasad SuyashSVP, Chief Med OfficerS - Sale+OE$30.06-10,00018,236-35%-$300,553
D
2019-02-25
BOLDAudentes Therapeutics, Inc.Patterson Matthew RCEOS - Sale+OE$30.00-21,000290,514-7%-$630,000
2019-02-25
CRSPCrispr Therapeutics AGNovak RodgerPresS - Sale$40.00-14,7801,033,227-1%-$591,233
D
2019-02-25
FATEFate Therapeutics IncTahl CindyGC, SecretaryS - Sale+OE$16.07-25,00090,418-22%-$401,820
2019-02-22
ACORAcorda Therapeutics IncSabella Lauren MChief Commercial OfficerS - Sale$13.18-7615,092-13%-$10,028
2019-02-22
ACORAcorda Therapeutics IncLawrence DavidChief, Bus. Ops, PAOS - Sale$13.18-7615,092-13%-$10,028
D
2019-02-22
AMRNAmarin Corp PlcukVan Heek G JanDirS - Sale+OE$20.02-203,38214,168-93%-$4,071,423
D
2019-02-20
EDITEditas Medicine, Inc.Myer VickeshCTOS - Sale+OE$20.42-3,0000-100%-$61,260
2019-02-20
MNTAMomenta Pharmaceuticals IncWheeler Craig APres, CEOS - Sale$14.08-1,435578,1940%-$20,205
2019-02-20
MNTAMomenta Pharmaceuticals IncKwon YoungSVP, Chief Business OfficerS - Sale$14.05-351125,8830%-$4,932
2019-02-20
MNTAMomenta Pharmaceuticals IncFier IanChief Mfg, Program OfficerS - Sale$14.05-35187,5660%-$4,932
D
2019-02-19
TCRRTcr2 Therapeutics Inc.Ubs Oncology Impact Fund L.P.10%P - Purchase$15.00+666,6673,370,982+25%+$10,000,005
D
2019-02-19
TCRRTcr2 Therapeutics Inc.Mpm Sunstates Fund, L.P.10%P - Purchase$15.00+706,6664,050,865+21%+$10,599,990
D
2019-02-19
TCRRTcr2 Therapeutics Inc.Mpm Bioventures 2014, L.P.10%P - Purchase$15.00+706,6664,050,865+21%+$10,599,990
D
2019-02-19
TCRRTcr2 Therapeutics Inc.Jovan-Embiricos MoranaDir, 10%P - Purchase$15.00+666,667536,962-514%+$10,000,005
D
2019-02-19
TCRRTcr2 Therapeutics Inc.Upnorth Investment Ltd10%P - Purchase$15.00+200,0002,137,419+10%+$3,000,000
D
2019-02-19
TCRRTcr2 Therapeutics Inc.Gadicke AnsbertDir, 10%P - Purchase$15.00+1,373,3331,569,235+701%+$20,599,995
M
2019-02-19
MNTAMomenta Pharmaceuticals IncBeltramello Jo AnnChief HR, Inf. OfficerS - Sale$13.64-8,780141,333-6%-$119,757
A
2019-02-03
HALOHalozyme Therapeutics IncChondros DimitriosSVP, Chief Medical OfficerS - Sale$16.41-2,53631,566-7%-$41,616
D
2019-02-19
GILDGilead Sciences IncWilson Gayle EDirS - Sale+OE$67.08-19,068124,499-13%-$1,279,074
2019-02-15
ATRAAtara Biotherapeutics, Inc.Haqq ChristopherEVP, R, D, Chief Scientific OfS - Sale$39.59-775291,9430%-$30,682
D
2019-02-15
ATRAAtara Biotherapeutics, Inc.Porter DerrellSVP, Head of Global CommercialS - Sale+OE$40.00-5,90921,688-21%-$236,360
D
2019-02-14
GNCAGenocea Biosciences, Inc.Sonsini Peter W.10%P - Purchase$0.47+9,948,26934,948,269+40%+$4,688,619
D
2019-02-14
GNCAGenocea Biosciences, Inc.Sandell Scott D10%P - Purchase$0.47+9,948,26934,948,269+40%+$4,688,619
D
2019-02-14
GNCAGenocea Biosciences, Inc.Mott David M10%P - Purchase$0.47+9,948,26934,948,269+40%+$4,688,619
D
2019-02-14
GNCAGenocea Biosciences, Inc.Makower Joshua10%P - Purchase$0.47+9,948,26934,948,269+40%+$4,688,619
D
2019-02-14
GNCAGenocea Biosciences, Inc.Makhzoumi Mohamad10%P - Purchase$0.47+9,948,26934,948,269+40%+$4,688,619
D
2019-02-14
GNCAGenocea Biosciences, Inc.Florence Anthony A. Jr.10%P - Purchase$0.47+9,948,26934,948,269+40%+$4,688,619
D
2019-02-14
GNCAGenocea Biosciences, Inc.Chang Carmen10%P - Purchase$0.47+9,948,26934,948,269+40%+$4,688,619
D
2019-02-14
GNCAGenocea Biosciences, Inc.Behbahani AliDir, 10%P - Purchase$0.47+9,948,26934,948,269+40%+$4,688,619
D
2019-02-14
GNCAGenocea Biosciences, Inc.Baskett Forest10%P - Purchase$0.47+9,948,26934,948,269+40%+$4,688,619
D
2019-02-14
GNCAGenocea Biosciences, Inc.Barris Peter J10%P - Purchase$0.47+9,948,26934,948,269+40%+$4,688,619
D
2019-02-14
GNCAGenocea Biosciences, Inc.New Enterprise Associates 16, L.P.10%P - Purchase$0.47+9,948,26934,948,269+40%+$4,688,619
2019-02-13
MNTAMomenta Pharmaceuticals IncWheeler Craig APres, CEOS - Sale$12.67-16,875579,629-3%-$213,806
2019-02-14
MNTAMomenta Pharmaceuticals IncRobertson MichelleCFOS - Sale$13.10-70311,526-6%-$9,209
2019-02-14
MNTAMomenta Pharmaceuticals IncManning Anthony M.Chief Scientific OfficerS - Sale$13.10-4,44976,001-6%-$58,282
2019-02-14
MNTAMomenta Pharmaceuticals IncKwon YoungSVP, Chief Business OfficerS - Sale$13.10-4,450126,234-3%-$58,295
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top